Cerus Corporation CERS
Super Investor & Insider
| Data filing | Data op. | Insider | Ruolo | Tipo | Prezzo | Quantità | Valore |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | 2026-06-09 | Bjerkholt Eric | Dir | Vendita | $2.60 | -20,454 | $53,180 |
| 2026-06-02 | 2026-05-29 | Jayaraman Vivek K | Chief Operating Officer | Vendita | $3.00 | -16,667 | $50,001 |
| 2026-05-05 | 2026-05-01 | Jayaraman Vivek K | Chief Operating Officer | Vendita | $3.00 | -16,667 | $50,001 |
| 2026-03-16 | 2026-03-12 | Jayaraman Vivek K | Chief Operating Officer | Vendita | $1.66 | -165,200 | $273,769 |
| 2026-03-16 | 2026-03-12 | Greenman William Mariner | President and CEO | Vendita | $1.66 | -447,757 | $742,023 |
| 2026-03-16 | 2026-03-12 | Green Kevin Dennis | Chief Financial Officer | Vendita | $1.66 | -127,544 | $211,366 |
| 2026-03-16 | 2026-03-12 | Benjamin Richard J | Chief Medical Officer | Vendita | $1.66 | -101,740 | $168,604 |
| 2026-03-16 | 2025-03-12 | Jensen Chrystal | Chief Legal Officer | Vendita | $1.66 | -113,008 | $187,277 |
| 2026-03-09 | 2026-03-09 | Benjamin Richard J | Chief Medical Officer | Vendita | $1.88 | -40,426 | $76,029 |
| 2026-03-09 | 2026-03-06 | Green Kevin Dennis | Chief Financial Officer | Vendita | $2.01 | -27,796 | $55,745 |
| 2026-03-09 | 2026-03-06 | Benjamin Richard J | Chief Medical Officer | Vendita | $2.01 | -24,235 | $48,603 |
| 2026-03-09 | 2026-03-06 | Jensen Chrystal | Chief Legal Officer | Vendita | $2.01 | -30,845 | $61,860 |
| 2026-03-09 | 2026-03-06 | Jayaraman Vivek K | Chief Operating Officer | Vendita | $2.01 | -34,094 | $68,376 |
| 2026-03-09 | 2026-03-06 | Greenman William Mariner | President and CEO | Vendita | $2.01 | -78,187 | $156,804 |
| 2026-03-09 | 2026-03-05 | Green Kevin Dennis | Chief Financial Officer | Vendita | $2.06 | -55,225 | $113,902 |
| 2026-03-09 | 2026-03-05 | Benjamin Richard J | Chief Medical Officer | Vendita | $2.06 | -61,233 | $126,305 |
| 2025-11-26 | 2025-11-24 | Jensen Chrystal | Chief Legal Officer | Vendita | $1.70 | -55,000 | $93,500 |
| 2025-08-25 | 2025-08-25 | Gregory Dean A. | Dir | Acquisto | $1.25 | +25,000 | $31,250 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Cerus Corporation is a biomedical products company dedicated to enhancing blood transfusion safety through its INTERCEPT Blood System. This platform inactivates a broad range of pathogens, including viruses, bacteria, and parasites, in blood components to reduce the risk of transfusion-transmitted infections. The INTER…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees261
TickerCERS
Statistics
Market Cap$507.8M
Revenue (TTM)$233.8M
Net Income-$15.6M
Net Margin-6.7%
EPS$-0.08
P/E-32.94
P/S2.40
P/B7.69
EV/EBITDA-328.35
ROE-15.4%
Dividend Yield—
Price$2.54
Data: Twelve Data · Revenue = mcap / P/S